White Clot Formations – Analysis Reveals Probable Link To mRNA Vaccine Toxic Ingredients
In 2022, lab director, Mike Adams conducted mass spectrometry analysis of the clots which were extracted out of the dead bodies, following the roll-out of the COVID-19 vaccines. His findings showed that the clots found in those dead bodies were made of a substance which is not naturally occurring but contains a number of metallic and non-metallic elements which again were not normally occurring in humans.
Mr Adams finding were suppressed and maligned by government health authorities throughout the world.
Fortunately, others have continued the research into the origins of these clots, as they are still found bodies that are being embalmed today.
This article focuses on a recent podcast which featured, polymer chemist (Greg Harrison) who has conducted more extensive research on these clots and other embalmers who are concerned about the prevalence of this phenomena.
The podcast, held in July 2024, is just under 2 hours and goes into explanations on why this phenomena occurs and why it does not affect everybody in the same way.
As a medical practitioner, I felt that it was worth writing a condensed excerpt of the podcast which gives details of the testing methodology and the conclusions drawn. Since this purpose of this website it to expose “hidden gems” of wisdom which are currently being censored. This one in particular, still has an impact on the lives of many people.
Do yourself a favour and take the time to look at this video first-hand, as this will help you to make more informed health care choices.
Nova Scotia Free Speech Bulletin Podcast host Tony Lohnes
Tony Lohnes – host
Deborah George – Funeral director
Greg Harrison – Polymer chemist.
Richard Hirschman – Funeral embalmer
John O’Looney – Funeral embalmer
Greg Harrison Investigates the Composition and Formation Mechanism of White Clots in Vaccinated Individuals
Recent studies have shed light on the composition and formation mechanisms of unusual white clots observed in certain vaccinated individuals. Greg Harrison, a polymer chemist, provides a detailed analysis of these clots, presenting findings from his research and collaborations with other scientists. This article summaries the key points of the investigation, offering insights into the biochemical pathways and potential implications for public health.
Composition Analysis Using ICP and HPLC
The investigation into the white clots began with an elemental analysis using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). This technique identified high levels of phosphorus, sodium, tin, sulphur, and carbon in the clots. The analysis was conducted by Mike Adams in the USA, with samples provided by Richard Hirschman. The findings were later confirmed by two independent laboratories in Europe.
- Elemental Composition: The ICP-MS results consistently showed aberrantly high levels of phosphorus, sodium, tin, sulphur, and carbon, with a notable absence of typical blood marker elements.
- Protein Composition: High-Performance Liquid Chromatography (HPLC) further revealed the protein composition of the white clots. The analysis identified an unusual ratio of fibrinogen chains, with a higher prevalence of beta chains compared to alpha and gamma chains, indicating an atypical fibrinogen structure.
Role of Phosphorus in White Clot Formation
Phosphorus plays a critical role in the formation of these white clots, primarily due to its involvement in the nucleation process and interaction with fibrinogen. Mr Harrison provided a detailed explanation of this mechanism, emphasising the unique biochemical properties of phosphorus.
- Phosphorus-Driven Nucleation: The lipid nanoparticles used in mRNA vaccines, particularly those containing DSPC (Distearoylphosphatidylcholine), release phosphorus as they deliver their mRNA payload into the bloodstream. This phosphorus is not part of the natural blood composition, which typically contains phosphate in small amounts. The released phosphorus interacts with fibrinogen, a key protein involved in blood clotting.
- Phosphorus and Fibrinogen Interaction: The phosphorus heads from the lipid nanoparticles bind to fibrinogen molecules, creating a scaffold that promotes the aggregation of fibrinogen chains. This interaction leads to the formation of a dense network of fibrin, deviating from normal clotting processes. The presence of excess phosphorus acts as a catalyst for fibrinogen polymerization, resulting in the formation of the unusual white clots.
- Enhancement of Coagulation Pathways: Phosphorus further enhances coagulation by stabilising fibrinogen structures, leading to a more robust clotting response. This stabilisation is distinct from physiological clot formation, which involves balanced regulation of fibrinogen and thrombin activity. The excess phosphorus disrupts this balance, contributing to pathological clot development.
Potential Mechanisms of White Clot Formation
In addition to the role of phosphorus, the formation of white clots is hypothesised to be linked to the lipid nanoparticle delivery systems used in certain mRNA vaccines. The key steps in the proposed mechanism are as follows:
- Phospholipid Interaction: The lipid nanoparticles contain a phospholipid called DSPC (Distearoylphosphatidylcholine), which releases its mRNA core upon entering the bloodstream. This release exposes phosphorus heads, which interact with naturally occurring fibrinogen.
- Nucleation Process: The interaction between phosphorus and fibrinogen leads to nucleation, forming what is described as “sandy blood.” This nucleation process is crucial for the development of white clots.
- Spike Protein Involvement: The spike protein generated from the mRNA vaccine binds to the phosphorylated fibrinogen, promoting further coagulation and growth of the clots. These clots anchor to damaged endothelial layers, exacerbating vascular damage and inflammation.
Factors Influencing Clot Formation
Several factors influence the likelihood of clot formation in individuals:
- Vaccination Dose and Type: The risk increases with the number of vaccine doses received. The analysis suggests that individuals receiving more than three doses, particularly of the Moderna vaccine, are more susceptible to developing white clots due to higher phospholipid concentrations.
- Blood Type: Individuals with blood types B, A, and AB are more prone to clot formation, while those with blood type O are relatively less susceptible due to lower affinity for fibrinogen adhesion.
- Vaccine Composition: Differences between Pfizer and Moderna vaccines also play a role. The Moderna vaccine produces an open conformation of the spike protein, increasing the surface area for potential interactions and enhancing the likelihood of clot formation.
Implications and Future Directions
Mr Harrison says he and his team “can prove all this,” and have 200 peer-reviewed studies that support their theory.
The research underscores the need for continued investigation into the biochemical pathways associated with mRNA vaccines. Understanding the mechanisms of clot formation and the role of phosphorus is critical for developing safer vaccination strategies and mitigating risks. Further studies are warranted to explore individual variability in response to vaccination and to establish evidence-based guidelines for vaccine administration.